Cargando…

Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis

BACKGROUND: Wnt-catenin signaling antagonists sclerostin and dickkopf-related protein-1 (Dkk-1) inhibit bone formation and are involved in the pathogenesis of postmenopausal osteoporosis (PO). However, the association between sclerostin and Dkk-1 and bone mineral density (BMD) in women with PO remai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Jia, Dong, Zhang, Hui, Zhang, Aifei, Wang, Lianfu, Deng, Youjia, Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152077/ https://www.ncbi.nlm.nih.gov/pubmed/34034718 http://dx.doi.org/10.1186/s12891-021-04365-8

Ejemplares similares

Bone Matrix Levels of Dickkopf and Sclerostin are Positively Correlated with Bone Mass and Strength in Postmenopausal Osteoporosis
por: Ueland, Thor, et al.
Publicado: (2019)

Bone microarchitecture and bone mineral density in Graves’ disease
por: Boro, Hiya, et al.
Publicado: (2023)

Denosumab improves bone mineral density and microarchitecture and reduces bone pain in women with osteoporosis with and without glucocorticoid treatment
por: Petranova, Tzvetanka, et al.
Publicado: (2014)

Assessment of bone mineral density by DXA and the trabecular microarchitecture of the calcaneum by texture analysis in pre- and postmenopausal women in the evaluation of osteoporosis
por: Karunanithi, R., et al.
Publicado: (2007)

Bone microarchitecture in ankylosing spondylitis and the association with bone mineral density, fractures, and syndesmophytes
por: Klingberg, Eva, et al.
Publicado: (2013)

Bone mineral density and bone microarchitecture in a cohort of patients with Erdheim-Chester Disease
por: He, Tianhua, et al.
Publicado: (2020)

Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis
por: Sánchez, A., et al.
Publicado: (2016)

Serum Dickkopf-1 Level in Postmenopausal Females: Correlation with Bone Mineral Density and Serum Biochemical Markers
por: Ahmed, Sahar Fathi, et al.
Publicado: (2013)

Dynamics of Bone Disease Biomarkers Dickkopf-1 and Sclerostin in Patients with Multiple Myeloma
por: Gerov, Vladimir, et al.
Publicado: (2023)

Bone density, microarchitecture and stiffness in Caucasian and Caribbean Hispanic postmenopausal American women
por: Zhou, Bin, et al.
Publicado: (2014)

Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis
por: Wakolbinger, Robert, et al.
Publicado: (2020)

Bone Microarchitecture of the Tibial Plateau in Health and Osteoporosis
por: Krause, Matthias, et al.
Publicado: (2017)

Gut microbiota and metabolite alterations associated with reduced bone mineral density or bone metabolic indexes in postmenopausal osteoporosis
por: He, Jianquan, et al.
Publicado: (2020)

Association of a history of gestational diabetes mellitus with osteoporosis, bone mineral density, and trabecular bone score in postmenopausal women
por: Lu, Boqi, et al.
Publicado: (2023)

Circulating sclerostin is associated with bone mineral density independent of HIV-serostatus
por: Ross, Ryan D., et al.
Publicado: (2020)

RF06 | PSAT147 Impairments in volumetric bone mineral density, bone microarchitecture, and estimated strength in women with atypical anorexia nervosa
por: Eddy, Kamryn, et al.
Publicado: (2022)

Normal bone mineral density and bone microarchitecture in adult males with high and low risk of exercise addiction
por: Hansen, Stinus Gadegaard, et al.
Publicado: (2022)

Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
por: Chen, Yi, et al.
Publicado: (2021)

Type 2 Diabetes Mellitus Increases the Risk to Hip Fracture in Postmenopausal Osteoporosis by Deteriorating the Trabecular Bone Microarchitecture and Bone Mass
por: Mohsin, Sahar, et al.
Publicado: (2019)

Diabetes mellitus accelerates the progression of osteoarthritis in streptozotocin-induced diabetic mice by deteriorating bone microarchitecture, bone mineral composition, and bone strength of subchondral bone
por: Wang, Hua-Jun, et al.
Publicado: (2021)

Association of Serum Periostin Level with Classical Bone Turnover Markers and Bone Mineral Density in Shanghai Chinese Postmenopausal Women with Osteoporosis
por: Li, Ran, et al.
Publicado: (2021)

Bone Microarchitecture in Obese Postmenopausal Chinese Women: The Chinese Vertebral Osteoporosis Study (ChiVOS)
por: Qi, Wenting, et al.
Publicado: (2022)

Anti-Sclerostin Antibodies in Osteoporosis and Other Bone Diseases
por: Fabre, Stéphanie, et al.
Publicado: (2020)

Analysis of three-dimensional bone mineral density and bone strength measured by quantitative computed tomography following denosumab discontinuation in a patient with postmenopausal osteoporosis
por: Tsuchiya, Koki, et al.
Publicado: (2019)

Feasibility of Bone Mineral Density and Bone Microarchitecture Assessment Using Deep Learning With a Convolutional Neural Network
por: Yoshida, Kazuki, et al.
Publicado: (2023)

Abstract 153: Bone microarchitecture, bone mineral density and bone turnover in association with glycemia and insulin action in women with prior gestational diabetes
por: Kubihal, Suraj, et al.
Publicado: (2022)

Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2009)

Comparison of Denosumab and Zoledronic Acid in Postmenopausal Women With Osteoporosis: Bone Mineral Density (BMD) and Trabecular Bone Score (TBS)
por: Kang, Taewook, et al.
Publicado: (2022)

Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis
por: Khanizadeh, Fatemeh, et al.
Publicado: (2018)

Effect of Traditional Chinese Medicine Product, QiangGuYin, on Bone Mineral Density and Bone Turnover in Chinese Postmenopausal Osteoporosis
por: Shi, Zhen-Yu, et al.
Publicado: (2017)

Serum Sclerostin Level Is Negatively Associated with Bone Mineral Density in Hemodialysis Patients
por: Lu, Jing-Wun, et al.
Publicado: (2022)

Compartment‐specific effects of muscle strength on bone microarchitecture in women at high risk of osteoporosis
por: Simon, Alexander, et al.
Publicado: (2022)

Utility and validation of bone mineral density measurements at forearm in predicting trabecular microarchitecture and central‐site osteoporosis in aging Indian postmenopausal women—a promising surrogate?
por: Gautam, Krishna Prabha, et al.
Publicado: (2022)

Muscular strength measurements indicate bone mineral density loss in postmenopausal women
por: Zhou, Zhixiong, et al.
Publicado: (2013)

Spine trabecular bone scores and bone mineral density of postmenopausal Taiwanese women
por: Huang, Mei-Lan, et al.
Publicado: (2022)

Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength of Intact Bones in Adult Male Rats
por: Suen, Pui Kit, et al.
Publicado: (2015)

Age-related changes in size, bone microarchitecture and volumetric bone mineral density of the mandible in the harbor seal (Phoca vitulina)
por: Kahle, Patricia, et al.
Publicado: (2019)

Moderate-Intensity Exercise Preserves Bone Mineral Density and Improves Femoral Trabecular Bone Microarchitecture in Middle-Aged Mice
por: Lee, Seungyong, et al.
Publicado: (2022)

The Trabecular Bone Score Predicts Spine Fragility Fractures in Postmenopausal Caucasian Women Without Osteoporosis Independently of Bone Mineral Density
por: Ripamonti, Claudio, et al.
Publicado: (2018)

Influence on the bone mineral density and bone metabolism marker after the interruption and reinitiation of monthly minodronate therapy in postmenopausal women with osteoporosis
por: Okimoto, Nobukazu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lkjsfjlkgmunu2dunt514e3ml2